HKG Equity Snapshot

1167 Weekly Equity Report

Jacobio Pharmaceuticals Group Co., Ltd.

Interactive chart JSON snapshot
Latest Close 4.65 HKD 12 Jun 2026
1W Return 12.3% latest completed week
4W Return -19.1% short-term follow-through
12W Return -30.4% quarterly tape
Trend Breadth 55.8% 29 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
Company Brief

What the company does

Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies in the People's Republic of China. The company develops sitneprotafib (JAB-3312), an oral allosteric SHP2 inhibitor that is in a Phase III trial for non-small cell lung cancer (NSCLC); glecirasib (JAB-21822), a KRAS G12C allosteric inhibitor in Phase II trials for NSCLC, multi-tumor basket, and colorectal cancer; JAB-8263, a BET inhibitor that is in a Phase IIa trial for solid tumors and hematologic malignancies; JAB-BX102, a humanized monoclonal antibody against CD73, which is in a Phase …

Snapshot

What the weekly tape is saying

1167 closed the latest completed week at 4.65 HKD. The 4-week return is -19.1% and the 12-week return is -30.4%. Trend Signal is inactive, Market Dynamics is -1.00. Setup signature: Risk-first tape with a 14/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -31.1%
Volume 1.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 31 Persistence of active Trend Signal over the last year and current streak.
Momentum 0 Blend of 4-week and 12-week follow-through.
Dynamics 0 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 51 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
6.75 HKD
Vs Trend Line
-31.1%
Fair Value
4.18 HKD
Vs Fair Value
11.1%
52W High
11.80 HKD
52W Low
3.98 HKD
Drawdown
-60.6%
Range Position
8.6%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 12.3%
4W -19.1%
12W -30.4%
26W -49.0%
52W -10.1%

Trend read

Active Streak
0 weeks
52W Active Weeks
29
52W Active Breadth
55.8%
Sector Scope
HK Healthcare
Sector Rank
9 of 257
Sector Percentile
96.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.00
4W MD Change
-479.8%
Relative Strength
-32.12
4W RS Change
-55.1%
Expectation
Negative
Probability
43.28%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
18.0M
13W Average
14.7M
52W Average
26.9M
Vs 13W
1.2x
Vs 52W
0.7x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
8.3%
52W Volatility
12.2%
Upside Weeks
22
Downside Weeks
30
Downside Breadth
57.7%
Avg Gain / Loss
11.2% / -7.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Biotechnology
Currency
HKD
Market Cap
3.5B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 4.65 HKD 12.3% 6.75 HKD 4.18 HKD -1.00 -32.12 18.0M Off
5 Jun 2026 4.14 HKD -15.5% 6.83 HKD 4.19 HKD -0.80 -40.27 18.4M Off
29 May 2026 4.90 HKD -7.9% 6.91 HKD 4.20 HKD -0.41 -30.16 14.0M Off
22 May 2026 5.32 HKD -7.5% 6.99 HKD 4.21 HKD -0.08 -25.71 7.1M Off
15 May 2026 5.75 HKD -8.7% 7.05 HKD 4.22 HKD 0.26 -20.70 17.1M Off
8 May 2026 6.30 HKD -10.0% 7.11 HKD 4.22 HKD 0.64 -14.31 16.9M Off
1 May 2026 7.00 HKD -6.8% 7.17 HKD 4.23 HKD 0.65 -2.07 7.6M Off
24 Apr 2026 7.51 HKD -6.8% 7.25 HKD 4.23 HKD 0.62 4.93 12.4M Off
17 Apr 2026 8.06 HKD 11.6% 7.30 HKD 4.23 HKD 0.39 12.70 27.7M Off
10 Apr 2026 7.22 HKD 0.3% 7.39 HKD 4.22 HKD -0.30 3.17 6.6M Off
3 Apr 2026 7.20 HKD 0.7% 7.53 HKD 4.23 HKD -0.63 7.07 13.2M Off
27 Mar 2026 7.15 HKD 7.0% 7.67 HKD 4.23 HKD -1.04 7.99 19.7M Off
20 Mar 2026 6.68 HKD -4.4% 7.70 HKD 4.23 HKD -1.30 0.43 12.6M Off
13 Mar 2026 6.99 HKD 13.7% 7.75 HKD 4.24 HKD -1.30 5.24 22.5M Off